258 related articles for article (PubMed ID: 26458502)
21. ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.
Sato E; Nakayama K; Razia S; Nakamura K; Ishikawa M; Minamoto T; Ishibashi T; Yamashita H; Iida K; Kyo S
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890703
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells.
Lin JF; Lin YC; Tsai TF; Chen HE; Chou KY; Hwang TI
Drug Des Devel Ther; 2017; 11():1517-1533. PubMed ID: 28553083
[TBL] [Abstract][Full Text] [Related]
23. [Inhibition of Beclin 1 enhances apoptosis by H2O2 in glioma U251 cells].
Kong XX; Zhang HY; Chen ZQ; Fan XF; Gong YS
Sheng Li Xue Bao; 2011 Jun; 63(3):238-44. PubMed ID: 21681342
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of autophagy-potentiated chemosensitivity to cisplatin in laryngeal cancer Hep-2 cells.
Kang R; Wang ZH; Wang BQ; Zhang CM; Gao W; Feng Y; Bai T; Zhang HL; Huang-Pu H; Wen SX
Am J Otolaryngol; 2012; 33(6):678-84. PubMed ID: 22771248
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of BRCA2 enhances cisplatin and cisplatin-induced autophagy in ovarian cancer cells.
Wan B; Dai L; Wang L; Zhang Y; Huang H; Qian G; Yu T
Endocr Relat Cancer; 2018 Jan; 25(1):69-82. PubMed ID: 29066501
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of autophagy enhances cisplatin cytotoxicity in human adenoid cystic carcinoma cells of salivary glands.
Ma B; Liang LZ; Liao GQ; Liang YJ; Liu HC; Zheng GS; Su YX
J Oral Pathol Med; 2013 Nov; 42(10):774-80. PubMed ID: 23590333
[TBL] [Abstract][Full Text] [Related]
27. Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes.
Tan TZ; Ye J; Yee CV; Lim D; Ngoi NYL; Tan DSP; Huang RY
EBioMedicine; 2019 Dec; 50():203-210. PubMed ID: 31761620
[TBL] [Abstract][Full Text] [Related]
28. The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.
Chen S; Jiang YZ; Huang L; Zhou RJ; Yu KD; Liu Y; Shao ZM
Clin Cancer Res; 2013 Dec; 19(24):6853-62. PubMed ID: 24141623
[TBL] [Abstract][Full Text] [Related]
29. Autophagy-active beclin-1 correlates with favourable clinical outcome in non-Hodgkin lymphomas.
Nicotra G; Mercalli F; Peracchio C; Castino R; Follo C; Valente G; Isidoro C
Mod Pathol; 2010 Jul; 23(7):937-50. PubMed ID: 20473282
[TBL] [Abstract][Full Text] [Related]
30. A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer.
Ishibashi M; Nakayama K; Yeasmin S; Katagiri A; Iida K; Nakayama N; Fukumoto M; Miyazaki K
Clin Cancer Res; 2008 May; 14(10):3149-55. PubMed ID: 18483383
[TBL] [Abstract][Full Text] [Related]
31. The XAF1 tumor suppressor induces autophagic cell death via upregulation of Beclin-1 and inhibition of Akt pathway.
Sun PH; Zhu LM; Qiao MM; Zhang YP; Jiang SH; Wu YL; Tu SP
Cancer Lett; 2011 Nov; 310(2):170-80. PubMed ID: 21788101
[TBL] [Abstract][Full Text] [Related]
32. Autophagy is associated with chemoresistance in neuroblastoma.
Belounis A; Nyalendo C; Le Gall R; Imbriglio TV; Mahma M; Teira P; Beaunoyer M; Cournoyer S; Haddad E; Vassal G; Sartelet H
BMC Cancer; 2016 Nov; 16(1):891. PubMed ID: 27846885
[TBL] [Abstract][Full Text] [Related]
33. Expression and clinical significance of the autophagy proteins BECLIN 1 and LC3 in ovarian cancer.
Valente G; Morani F; Nicotra G; Fusco N; Peracchio C; Titone R; Alabiso O; Arisio R; Katsaros D; Benedetto C; Isidoro C
Biomed Res Int; 2014; 2014():462658. PubMed ID: 25136588
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Beclin 1 expression enhances cisplatin-induced apoptosis through a mitochondrial-dependent pathway in human ovarian cancer SKOV3/DDP cells.
Sun Y; Liu JH; Jin L; Sui YX; Lai L; Yang Y
Oncol Res; 2014; 21(5):261-9. PubMed ID: 24854102
[TBL] [Abstract][Full Text] [Related]
35. Prognostic determinants in patients with uterine and ovarian clear carcinoma.
Rauh-Hain JA; Winograd D; Growdon WB; Schorge JO; Goodman AK; Boruta DM; Berkowitz RS; Horowitz NS; Del Carmen MG
Gynecol Oncol; 2012 May; 125(2):376-80. PubMed ID: 22366593
[TBL] [Abstract][Full Text] [Related]
36. Clear cell carcinoma of the ovary: Clinicopathologic features and outcomes in a Chinese cohort.
Tang H; Liu Y; Wang X; Guan L; Chen W; Jiang H; Lu Y
Medicine (Baltimore); 2018 May; 97(21):e10881. PubMed ID: 29794794
[TBL] [Abstract][Full Text] [Related]
37. Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer.
Shen Y; Li DD; Wang LL; Deng R; Zhu XF
Autophagy; 2008 Nov; 4(8):1067-8. PubMed ID: 18776739
[TBL] [Abstract][Full Text] [Related]
38. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers.
Ahn CH; Jeong EG; Lee JW; Kim MS; Kim SH; Kim SS; Yoo NJ; Lee SH
APMIS; 2007 Dec; 115(12):1344-9. PubMed ID: 18184403
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy.
Xu R; Liu S; Chen H; Lao L
Oncol Rep; 2016 Mar; 35(3):1757-63. PubMed ID: 26708607
[TBL] [Abstract][Full Text] [Related]
40. Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary.
Sekiya R; Kajiyama H; Sakai K; Umezu T; Mizuno M; Shibata K; Yamamoto E; Fujiwara S; Nagasaka T; Kikkawa F
Hum Pathol; 2012 Jun; 43(6):904-10. PubMed ID: 22169254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
